Safety profile and clinical activity of sifalimumab, a fully human anti-interferon α monoclonal antibody, in systemic lupus erythematosus: A phase I, multicentre, double-blind randomised study
Joan T. Merrill, Daniel J. Wallace, Michelle Petri, Kyriakos A. Kirou, Yihong Yao, Wendy I. White, Gabriel Robbie, Robert Levin, Seth M. Berney, Vishala Chindalore, Nancy Olsen, Laura Richman, Chenxiong Le, Bahija Jallal, Barbara White
Dive into the research topics of 'Safety profile and clinical activity of sifalimumab, a fully human anti-interferon α monoclonal antibody, in systemic lupus erythematosus: A phase I, multicentre, double-blind randomised study'. Together they form a unique fingerprint.